Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3BNC117 and 10-1074 in HIV-uninfected adults
NCT02824536Phase 1Completed
- Sponsor
- The Rockefeller University
- Start
- Jun 2016
- Primary completion
- Jan 2018
- Modality
- Anti-infectious Disease mAbs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Teropavimab and zinlirvimab in human immunodeficiency virus infection (HIV), sponsored by The Rockefeller University. Started Jun 2016; status: completed.
02
Drugs
Teropavimabzinlirvimab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02824536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02824536.